Opus Genetics: Clinical Trials & Research Profile
Biopharma Industry (Global / Institutional) · Primary Focus: Rare Genetic, Women's Health, and Other
| Clinical Trial Metric | Verified Public Record |
|---|---|
| Organization Type | Consolidated Trial Sponsor |
| Institutional Sector & Location | Biopharma Industry (Global / Institutional) |
| Primary Therapeutic Area | Rare Genetic, Women's Health, and Other |
| Active Phase II & III Studies | 4 active (4 recruiting now) |
| Total Tracked Studies (2018 to 2026) | 15 (11 with California sites) |
| Completed vs Early-Stopped Studies | 11 completed / 0 stopped (0.0% stop rate) |
| Median Closed Enrollment | 150 participants |
| FDA Drugs@FDA Original Approvals | 0 all-time (0 from 2018 to 2026) |
| Physical Hospital Site Disclosure | 60.4% named hospital slots |
Need custom healthcare data pipelines, identifier crosswalks, or workflow automation? Talk to Meru AI -> · AI for Healthcare · Healthcare Price & Patent Cliff Crosswalk